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Abstract
Background: Advanced glycation end products generated in the circulation of diabetic patients were reported to
affect the function of vascular wall. We examined the effects of advanced glycation end products-bovine serum
albumin (AGE-BSA) on endothelial connexin43 (Cx43) expression and gap-junction communication.
Results: In human aortic endothelial cells (HAEC) treated with a series concentrations of AGE-BSA (0-500 μg/ml) for
24 and 48 hours, Cx43 transcript and Cx43 protein were reduced in a dose dependent manner. In addition, gap-
junction communication was reduced. To clarify the mechanisms underlying the down-regulation, MAPKs pathways
in HAEC were examined. Both a MEK1 inhibitor (PD98059) and a p38 MAPK inhibitor (SB203580) significantly
reversed the reductions of Cx43 mRNA and protein induced by AGE-BSA. Consistently, phosphorylation of ERK and
p38 MAPK was enhanced in response to exposure to AGE-BSA. However, all reversions of down-regulated Cx43 by
inhibitors did not restore the functional gap-junction communication.
Conclusions: AGE-BSA down-regulated Cx43 expression in HAEC, mainly through reduced Cx43 transcription, and
the process involved activation of ERK and p38 MAPK.
Background
Diabetes is known to accelerate the process of athero-
sclerosis, in which endothelial dysfunction plays a key
role [1]. Previous studies have shown that diabetes alters
the expression of a variety of molecules involved in
maintenance of endothelial function [2]. Animal experi-
ments also demonstrated that induction of diabetes,
either alone or on top of hyperlipidemia, suppress the
expression of endothelial gap junctions [3,4]. Gap junc-
tions are cell membrane channels made of paired hex-
amers of connexins, which allow exchange of ions and
small signaling molecules between the cytoplasmic com-
partments of adjacent cells. In mammals endothelial
cells mainly express connexin43 (Cx43), Cx40, and Cx37
[5], of which Cx43 is by far the predominant in the cul-
tured endothelial cells [6,7]. Several reports have shown
that endothelial Cx43 gap junctions are down-regulated
by factors causing endothelial dysfunction [8], such as
aging [9], hypertension [10], and arsenic trioxide [11],
the last of which was even reported to induce endothe-
lial lesion. In contrast, other factors causing endothelial
dysfunction, such as oscillatory shear stress, were shown
to enhance Cx43 expression [12].
One key offending factor underlying the toxic effects
of diabetes is glucose, the high level of which had been
proved to affect the activities of endothelial cells in
many aspects, including suppression of gap junctions
[13,14]. Since diabetes is associated with a more severe
form of vascular disease, we suspected that molecules
underlying the detrimental effects of diabetes other than
glucose also affect endothelial gap junctions.
During chronic exposure to elevated blood glucose
advanced glycation end products (AGE) are generated in
the circulation. AGE are also versatile molecules and
have been reported to possess multiple actions in the
vascular wall, such as changes of release of cytokines,
induction of expression of cell adhesion molecules,
impairment of endothelial vasodilatation, and triggering
of chronic inflammation [15]. However, the effect of
AGE on endothelial gap junctions remained unclear. To
this end, we examined the expression of Cx43 as well as
the gap-junction communication in human aortic
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underlying mechanisms. A previous study had shown
that the average serum AGE levels in diabetic patients
ranged between 28.8 and 87.2 μg/ml and may reach
160-500 μg/ml in severe cases [16].
Methods
Generation of AGE-BSA
AGE-BSA was prepared by incubation of BSA (Fraction
V, Sigma Chemical Co., St. Louis, MO, USA) at a con-
c e n t r a t i o no f5 0m g / m lw i t h0 . 5Mg l u c o s ei n1 0m M
phosphate-buffered saline (PBS) containing 0.5 mM
EDTA, pH 7.4, at 37°C for 12 weeks. For a control
group, the same concentration of BSA was incubated
with PBS containing EDTA without glucose for 12
weeks. Free glucose was removed by extensive dialysis
against PBS. The brown color of AGE-BSA showed the
typical appearance of AGE. SDS-PAGE analysis showed
the formation of AGE-BSA monomer and dimer with
molecular weights approximately equaling to 78 and 157
kDa, respectively. However, unglycated BSA was about
69 kDa. The ratio of relative fluorescence intensities of
AGE-BSA to unglycated BSA was approximately 64
folds in our preparations. Results were consistent with
other’s report [17]. For a control group, BSA was pro-
cessed as above procedures. BSA and AGE-BSA were
stored at -70°C until use.
Cell culture
HAECs (Cascade Biologics) were seeded in 1% gelatin-
coated plasticware and incubated at 37°C under a humi-
dified 95% air and 5% CO2 atmosphere. Cells grown to
confluence were dissociated with 3 ml of 0.25% trypsin-
EDTA (GIBCO) at 37°C for 3 min. The suspension was
diluted with 7 ml medium 200 supplemented with
LSGS, centrifuged at 1200 rpm for 8 min, and resus-
pended in the culture medium. Cells were then replated
in 35-mm Petri dishes (5 × 10
4 cells per cm
2)a n d
a l l o w e dt og r o wt oc o n f l u e n c eo rs e e d e da tt h es a m e
density onto 12-mm glass coverslips coated with 1%
gelatin (Sigma). Cells of passage 4 to 6 were used in the
subsequent experiments. To evaluate the relative mRNA
level of Cx37, Cx40, and Cx43, human umbilical vein
endothelial cells (HUVEC, from PromoCell), maintained
in endothelial cell growth medium (EGM, from Promo-
Cell) were used as a reference. The confluent cells were
treated with AGE-BSA at series concentrations of 25,
50, 100, 250, and 500 μg/ml for 24 and 48 hours. For a
control group, cells were treated with BSA at series con-
centrations of 25, 50, 100, 250, and 500 μg/ml for 24
hours. For examination of activation of MAPK signaling
pathways, cells were incubated with AGE-BSA at con-
centrations of 25, 50, 100, 250, and 500 μg/ml for 2 and
6 hours. For time course experiments, cells were
incubated with AGE-BSA at 500 μg / m lf o r0 ,0 . 5 ,1 ,2 ,
4, and 6 hours. For drug treatments, cells were treated
with 40 μM of PD98059 (Sigma), 15 μM of SB203580
(Sigma), and 10 μM of SP600125 (Sigma) for 30 min
and then incubated with 500 μg/ml AGE-BSA for 24
hours.
Western blotting
Cells were collected in RIPA buffer containing 150 mM
NaCl, 5 mM EDTA, 1% NP40, 2 mM PMSF, and 50
mM Tris-HCl, pH 7.4 or SB buffer containing 20% SDS,
0.1 M Tris-HCl, pH 6.8, and 10 mM EDTA followed by
sonication for 30 sec. Thirty microgram of sample was
loaded in each lane, resolved by 12% SDS-PAGE, and
transferred onto a PVDF membrane (Amersham, UK).
The membrane was incubated with the monoclonal
anti-Cx43 antibody (1:1000; Chemicon), anti-Cx43 anti-
body (1:1000; BD Biosciences), anti-b actin antibody
(1:2000; Chemicon), anti-ERK antibody (1:1000; Cell sig-
naling), anti-p38 MAPK antibody (1:1000; Biosource),
anti-JNK antibody (1:2000; Cell signaling), anti-phos-
phorylated ERK antibody (1:1000; Cell signaling), anti-
phosphorylated p38 MAPK antibody (1:1000; Biosource),
and anti-phosphorylated JNK antibody (1:1000; Cell sig-
naling) at room temperature for 1 hour. After three
washes with TBST (20 mM Tris pH 7.6, 150 mM NaCl,
0.1% Tween 20), a horseradish peroxidase-conjugated
mouse anti-rabbit or donkey anti-mouse IgG (1:3000 in
TBST plus 10% BSA) was added, and an enzyme-linked
chemiluminescence system (ECL; Amersham, UK) was
applied to check the bound antibody.
Real-time PCR and Semi-quantitative RT-PCR
Total RNA was extracted using Trizol reagent (Invitro-
gen Life Technologies, Carlsbad, USA) according to the
manufacturer’s instructions. After phenol treatment and
drying, RNA was dissolved in RNase-free water for
determination of concentration using spectrophot-
ometer. RNA quality was checked on agarose electro-
phoresis. For real-time PCR analysis, endothelial cDNA
were amplified with primers specific for Cx43 (sense: 5’-
CCT CTC GCC TAT GTC TCC TC-3’)( a n t i s e n s e :5 ’-
GCT CAC TTG CTT GCT TGT TG-3’), Cx37 (sense:
5’-CGT AGA GCG TCA GAT GGC-3’) (antisense: 5’-
GCA CAC TGG CGA CAT AGG-3’), Cx40 (sense: 5’-
TCA ATC CCT TCA GCA ATA ATA TG-3’)( a n t i -
sense: 5’-GTG ACC TGG TGA GAC TCC-3’), and b-
actin (sense: 5’-TCC TGT GGC ATC CAC GAA ACT-
3’)( a n t i s e n s e :5 ’-GAA GCA TTT GCG GTG GAC
GAT-3’) using iQTM SYBR Green Supermix reagent
and detected with iQTM Single Color Real-Time PCR
Detector System (all from Bio-Rad, California, USA).
Relative mRNA levels were normalized with the corre-
sponding levels of b-actin.
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reverse-transcribed into complementary DNA (cDNA)
using the SuperScrip™ II reverse transcriptase and ran-
dom primers (Invitrogen Life Technologies) according
to the manufacturer’s recommendations and diluted
with DDW to a final volume of 20 μl. The optimal
number of PCR cycles was determined for Cx43 (Cx-1:
5’-TCTGAGTGCCTGAACTTGC-3’ and Cx-2: 5’-ACT-
GACAGCCACACCTTCC-3’) and GADPH (GA-1: 5’-
CATTGACCTCAACTACATGG-3’ and GA-2: 5’-
TTGCCCACAGCCTTGGCAGC-3’) so that the amplifi-
cation process was conducted during the exponential
phase of amplification. Amplification of the GADPH
gene transcript was used as the internal control to strin-
gently control for any variability in RNA degradation
and RT efficiency. Reactions were carried out in a 50 μl
final reaction volume.
Immunofluorescence detection
Confluent cells grown on coverslips were fixed with
methanol at -20°C for 5 min. After blocking with 0.5%
BSA, the cells were incubated with the anti-Cx43 anti-
body (1:1000; Chemicon) at 37°C for 1 hour, followed
by incubation with a CY3 conjugated donkey anti-
mouse antibody (Chemicon). The cells were then incu-
bated with FITC-conjugated lectin Ulex europaeus
agglutinin-1 (UEA-1; 10 μg/ml; Sigma) for 1 hour to
confirm the identity of endothelial cells [18] or bisben-
zamide (1 μg/ml; Sigma) for 15 min. Finally, the cells
were mounted and examined using a Leica TCS SP con-
focal laser scanning microscope.
Scrape loading assay
Gap-junction communication in HAECs treated with
250 and 500 μg/ml of AGE-BSA for 24 and 48 hours
was evaluated by scrape loading assay. For drug experi-
ments, HAEC were respectively pretreated with i) 40
μM of PD98059 and ii) 15 μM of SB203580 prior to
addition of the AGE-BSA (500 μg/ml) for 24 hours. The
medium of confluent cells were removed and rinsed
with Hank’s balanced salt solution (GIBCO). A 27-gau-
age needle was used to create multiple scrapes through
the cell monolayer in the presence of PBS containing
0.5% rhodamine-dextran and 0.5% Lucifer yellow. After
3 min of incubation at room temperature, the culture
was rinsed three times and then incubated for 5 min in
medium 200 supplemented with LSGS to allow the
loaded dye to transfer to adjoining cells. The cells were
viewed and recorded using a fluorescence microscope.
MTT assay
Cells were incubated in medium 200 supplemented with
LSGS containing 0.5 mg/ml MTT [3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide]. After 1
hour, the MTT solution was removed and dimethylsulf-
oxide (100 μl/well) was added.
Absorbances (550 nm) of the supernatant were read
using a microplate spectrophotometer (Spectra Max
340; Molecular Devices, Sunnyvale, CA). Cell viability
w a se x p r e s s e da st h ep e r c e n t a g eo ft h ea b s o r b a n c e
values of treated cells to controls.
Analysis
Densitometric scanning and analysis were performed on
immunoblots and gel images using Imagemaster (Amer-
sham Pharmacia Biotec, NJ, USA). Within each lane,
total amounts of bands of Cx43 were divided by those
of actins as loading controls. For RT-PCR, amounts of
Cx43 were divided by those of GADPH. For the scrape
loading assay, the area between the bilateral edges of
lucifer yellow transfer and the scrape line was measured.
The value of total amount of each sample was presented
as mean (%) ± S.E. The significant differences are ana-
lyzed by t-test.
Results
Real-time PCR showed that Cx37, Cx40, and Cx43
existed in both HAEC and HUVEC. However, the
expression levels differed markedly (Figure 1). Regarding
HAEC, Cx43 transcripts were more than 10-fold abun-
dant, compared to Cx37 or Cx40 (Cx43 vs. Cx37 or
Cx40, both P <0.01), in contrast to HUVEC, in which
Figure 1 Analysis of the mRNA profile of Cx37, Cx40, and Cx43
in HAEC and HUVEC showed distinct expression patterns in
each type of cells and in HAEC Cx43 was the most abundant
transcripts. Real-time PCR showed the existence of Cx37, Cx40, and
Cx43 transcripts. Cx43 and Cx37 were the most abundant connexin
transcripts expressed in HAEC and HUVEC, respectively. In HAEC,
compared to Cx37 and Cx40, Cx43 was more than 10-fold
abundant. *, p < 0.05; #, p < 0.005, HAEC vs. HUVEC. **, p < 0.01 for
Cx43 vs. each of Cx37 and Cx40 in HAEC.
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Page 3 of 12Cx37 was the most abundant. In addition, the relative
mRNA expression levels of individual connexins in
HAEC were lower than those in HUVEC (all P <0.05,
see Figure 1). Consistently, immunoconfocal examina-
tion of the untreated HAEC showed that Cx43 was
abundantly expressed at the cell borders, typical for gap
junctions, but Cx37 and Cx40 were rarely seen (Figure
2). Treatment with AGE-BSA for 24 hours at doses of
100 and 500 μg/ml lead to a marked reduction of Cx43
and Cx37 and Cx40 remained rarely seen (Figure 2).
Therefore, the following experiments in HAEC were
focused on Cx43.
In cells treated with AGE-BSA at doses from 25 to
250 μg/ml for 24-48 hours, no changes of the cell den-
sity and morphology were observed (Figure 3). However,
cells became slightly retracted and reduced in density
after treated with 500 μg/ml of AGE-BSA for more than
24 hours (Figure 3L). For Cx43, regardless of the 24 or
48 hours treatment, the levels of expression gradually
decreased as the dose of AGE-BSA increased (Figure 3).
Figure 2 Expression of Cx37, Cx40, and Cx43 gap junctions in HAEC evaluated by immunoconfocal microscopy showed that in
untreated cells Cx43 was abundantly expressed at the cell borders but Cx37 and Cx40 were rarely observed. AGE-BSA reduced Cx43
signals in a dose-dependent manner. Images were respectively obtained from cells treated with 100 μg/ml and 500 μg/ml of AGE-BSA for 24
hours. Compared with the control group (A), Cx43 gap junctions (red spots) are reduced as the dose of AGE-BSA increases (B and C). Note no
conceivable signals of Cx37 and Cx40 were found in all cells. Blue label, nucleus. Green label, lectin UEA1. The concentration of AGE-BSA and the
incubation time are indicated in the upper left of each image. h, hours. All images are of the same magnification. Bar, 50 μm.
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Page 4 of 12Figure 3 Reduced expression of endothelial Cx43 gap junctions by AGE-BSA, as evaluated by immunoconfocal microscopy. The levels
of Cx43 decreased as the dose of AGE-BSA increased regardless of 24 or 48-hour treatment. Images A-F and G-L were respectively obtained
from cells treated with AGE-BSA for 24 and 48 hours. Compared with the control group (A and G), Cx43 gap junctions (red spots) are reduced as
the dose of AGE-BSA increases (B-F and H-L). Blue label, nucleus. The concentration of AGE-BSA and the incubation time are indicated in the
upper left of each image. h, hours. All images are of the same magnification. Bar, 50 μm.
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of AGE-BSA on Cx43 expression (Figure 4). After expo-
sure to 500 μg/ml of AGE-BSA for 24 hours (Figure 4A)
and 48 hours (Figure 4B), the relative expression levels
of Cx43 protein were respectively reduced to 61.2 ±
7.3% and 43.9 ± 8.8% (both P <0.05, compared to the
control groups). A control group of cells treated with
dialyzed, long term stored BSA for 24 hours showed no
changes of Cx43 proteins (Additional file 1 Figure S1).
There was no difference in decreasing trends or patterns
of Cx43 proteins extracted from AGE-BSA-treated cells
with lysis buffers containing NP40 or SDS as well as no
difference in Cx43 expression when the samples were
detected using anti-Cx43 antibodies from various
sources (Additional file 2 Figure 2S and Additional file 3
Figure 3S). The function of gap-junction communication
was checked using the method of scrape-loading/dye
transfer (Figure 5A). The areas of dye transfer were sig-
nificantly reduced in cells treated with 500 μg/ml of
AGE-BSA for 24 hours and 250 μg/ml of AGE-BSA for
48 hours (Figure 5B; both P <0.05). Moreover, because
cells were not well contacted after exposure to 500 μg/
ml of AGE-BSA for 48 hours, the inhibition of gap-junc-
tion communication was unable to quantify (Figure 5B).
The effects of AGE-BSA on viability of cells after expo-
sure for 24 hours were assessed using MTT assay. The
relative viability of cells was 94.2 ± 0.2% (100 μg/ml
AGE-BSA), 90.2 ± 1.4% (250 μg/ml AGE-BSA), and 81.6
±0 . 8 %( 5 0 0μg/ml AGE-BSA), respectively (all P <0.05,
compared to the control groups) (Figure 6).
To explore whether alteration of Cx43 expression by
AGE-BSA was regulated through MAPK cascades, three
signal pathways, ERK, JNK, and p38 MAPK were sepa-
rately blocked before addition of AGE-BSA. PD98059, an
MEK1 inhibitor which blocks ERK pathway, significantly
reversed the reduction of Cx43 proteins in cells treated
with AGE-BSA for 24 hours (relative expression levels,
without PD98059, 62.3 ± 4.8%; with PD98059, 84.1 ±
4.4%, p < 0.05 see Figure 7A). Similarly, SB203580, a p38
MAPK inhibitor, also significantly reversed the reductions
(without SB203580, 60.5 ± 1.6%; with SB203580, 79.6 ±
2.9%, p < 0.05 see Figure 7B). The basal levels of Cx43
proteins were not affected after the addition of these inhi-
bitors. In contrast, no such effects were seen in cells trea-
ted with SP600125, a JNK inhibitor (data not shown).
Immunoconfocal microscopy also confirmed that AGE-
BSA induced reduction of Cx43 was reversed by PD98059
or SB203580 to the levels comparable to the control group
and the reversed Cx43 mainly located at cell borders (Fig-
ure 7C). The gap-junction communication was measured
when cells were treated with 500 μg/ml of AGE-BSA for
24 hours in the presence of either PD98059 (40 μM) or
SB203580 (15 μM). Whereas Cx43 proteins returned to
approximately the control levels (Figure 7A-C), the areas
of dye transfer remained close to those of cells treated
with 500 μg/ml of AGE-BSA for 24 hours (all P <0.05,
compared to the control groups; see Figure 7D). Taken
together, our results indicated the reversed Cx43 by
MEK1 or p38 MAPK inhibitor remained at the cell bor-
ders but exhibited impaired communication function.
Figure 4 Dose-dependent reduction of expression of Cx43
protein by AGE-BSA, as detected by Western blotting. Note
that a dose-dependent reduction is seen in cells treated with AGE-
BSA for both 24 (A) and 48 hours (B). For each dose of treatment,
the relative level of the total amount of Cx43 protein is shown in
the histogram at the top of the blot. The relative expression levels
of Cx43 protein significantly reduced to 61.2 ± 7.3% and 43.9 ±
8.8% after cells exposure to 500 μg/ml of AGE-BSA for 24 and 48
hours, respectively. *, p < 0.05 compared to the untreated cells.
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protein synthesis at the transcription level, Cx43 tran-
scripts was measured using semi-quantitative RT-PCR,
which showed a dose-dependent decrease of the tran-
scripts in cells treated with AGE-BSA for 24 hours
(relative expression levels, 500 μg/ml of AGE-BSA, 57.1 ±
8.9%; p < 0.05 compared to the control group; see Figure
8A). This effect was more obvious after treatment for 48
hours (500 μg/ml of AGE-BSA, 38.3 ± 5.5%; p < 0.05; see
Figure 8B). Moreover, the decrement of Cx43 transcripts
at exposure of 500 μg/ml of AGE-BSA followed a time-
dependent manner, as early as 6 hours, a significant
decrease was noticed (77.5 ± 5.1%; p < 0.05; see Figure
8C). The down-regulation of Cx43 transcripts by AGE-
BSA (500 μg/ml) seen at 24 hours was significantly
reversed in cells pre-treated with PD98059 or SB203580
(without PD98059 or SB203580, 65.1 ± 2.1%; with
PD98059, 95.1 ± 5.3%; with SB203580, 98.8 ± 9.4%, all p <
0.05; see Figure 8D). No affections on the basal levels of
Cx43 transcripts were seen after the addition of these inhi-
bitors. This indicated that the AGE-BSA-induced reduc-
tion in Cx43 transcription was mediated by ERK and p38
MAPK. Phosphorylation of ERK and p38 MAPK was acti-
vated dose-dependently in cells treated with AGE-BSA for
2 hours (Figure 9A) and 6 hours (Figure 9B), while no
such change was seen in JNK. Taken together, these data
indicated that the down-regulation of Cx43 expression
was through ERK and p38 MAPK signaling pathways.
Discussion
This study demonstrates that, in cultured HAEC, i)
Cx43 is the predominant gap junction component pro-
tein, unlike HUVEC; ii) AGE-BSA reduced Cx43
Figure 5 Reduction of gap-junction communication by AGE-BSA, as evaluated using scrape loading assay. A. Bottom images are phase-
contrast micrographs of the upper fluorescent images. The concentration of AGE-BSA (in μg/ml) is indicated in the upper left of each paired
images. B. Analysis of the area between the bilateral edges of lucifer yellow transfer and the scrape line is shown in the histogram. Bar, 150 μm.
Note that significant decrements were seen in cells treated with 250 μg/ml for 24 and 48 hours, and 500 μg/ml for 24 hours, respectively. *, p <
0.05 compared to the untreated cells. h, hours. The inhibition of gap-junction communication at 500 μg/ml of AGE-BSA for 48 hours was not
quantified because cells were not well contacted.
Figure 6 Dose-dependent reduction in viability of cells treated
with AGE-BSA, as detected by MTT assay. Note a dose-
dependent reduction is seen in cells treated with AGE-BSA for 24
hours. For each dose of treatment, the relative level of the total
amount of cells is shown in the histogram. The relative viability of
cells significantly reduced to 94.2 ± 0.2%, 90.2 ± 1.4%, and 81.6 ±
0.8% post exposure to 100 μg/ml, 250 μg/ml, and 500 μg/ml,
respectively. *, p < 0.05 compared to the untreated cells.
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Page 7 of 12Figure 7 PD98059 and SB203580 respectively blocked the down-regulating effect of AGE-BSA on Cx43 protein (as detected by
Western blotting and immunoconfocal microscopy) but not the effect on the gap-junction communication (by scrape loading). Note
the relative expression levels of Cx43 in cells treated with AGE-BSA (500 μg/ml; 24 hours) were reversed from 62.3 ± 4.8% to 84.1 ± 4.4% by
PD98059 (A) and from 60.5 ± 1.6% to 79.6 ± 2.9% by SB203580 (B), respectively. The results were further confirmed by immunoconfocal
microscopy (C). The inhibition of gap-junction communication by AGE-BSA (500 μg/ml; 24 hours) was not rescued in the presence of PD98059
and SB203580 (D). *, p < 0.05 compared to the untreated cells. Images in (C) were obtained from the control group, cells treated with AGE-BSA,
cells treated with AGE-BSA and PD98059, and cells treated with AGE-BSA and SB203580, respectively. Note that Cx43 gap junctions (red spots)
were reversed near the level of the control group by PD98059 and SB203580. Blue label, nucleus. The concentrations of AGE-BSA and inhibitor
used are indicated in the upper left of each image. All images are of the same magnification. Bar, 50 μm.
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Page 8 of 12transcript expression in a time-dependent manner; and
iii) AGE-BSA reduced Cx43 protein expression and atte-
nuated gap-junction intercellular communication in a
dose-dependent manner; Although a substantial portion
of HAEC died when the cells were treated with high
dose of AGE-BSA (500 μg/ml) for more than 24 hours,
the down-regulating effects of AGE-BSA on Cx43
expression should not be mainly attributed to a general
reduction in protein expression during cell dying, since
the expression level of actin protein along the reduction
o fC x 4 3w a sr e l a t i v e l ys t a b l e( s e eF i g u r e4 ) .I na d d i t i o n ,
inhibition of gap-junction communication activity may
Figure 8 Reduced transcription of Cx43 by AGE-BSA and partial recovery of reduced Cx43 transcript by each of PD98059 and
SB203580, as detected by semi-quantitative RT-PCR. Note that a dose-dependent reduction is seen in cells treated with AGE-BSA for both
24 (A) and 48 hours (B); a time-dependent reduction is seen in cells treated with 500 μg/ml of AGE-BSA for different time periods (C). The
relative transcription levels of Cx43 of AGE-BSA-treated cells were significantly reversed by PD98059 from 65.1 ± 2.1% to 95.1 ± 5.3% or by
SB203580 from 65.1 ± 2.1% to 98.8 ± 9.4% (D). For each dose of treatment, the relative level of Cx43 transcripts is shown in the histogram at the
top of the blot. h, hours. *, p < 0.05 compared to the untreated cells.
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Page 9 of 12cause cell death, as seen in retinal capillary cells, in
which attenuation of gap-junction communication with
high glucose treatment disturbed normal transport of
small molecules and calcium ions, leading to cell death
[14,19]. The reduction of Cx43 transcripts by AGE-BSA
was partially recovered by inhibitors of each of the
ERK1 and p38 MAPK. Moreover, the activation of the
MAPK cascades was further confirmed by the increase
of phosphorylated ERK and p38 after a short time expo-
sure to AGE-BSA indicating that activation of both the
E R Ka n dp 3 8M A P Kc a s c a d e si si n v o l v e di nt h i sp r o -
cess. Despite the down-regulation of Cx43 expression by
AGE-BSA can be abrogated by the inhibitors and the
reversed Cx43 mainly stayed at the cell borders, the
gap-junction communication was impaired. These novel
findings are complementary to our current knowledge
regarding the effects of diabetes on endothelial gap
junctions.
The results of the present study, in conjunction with
those from other in vitro experiments investigating the
effect of high glucose on endothelial gap junctions
[13,14], indicate that in the circulation of diabetic indivi-
duals high glucose per se as well as the glycated albu-
min, which is generated in high glucose milieu, affects
endothelial gap junction. Interestingly, both the actions
of high glucose and the glycated albumin on endothelial
gap junctions may share similar mechanisms. In cul-
tured microvasular endothelial cells treated with high
glucose, the Cx43 mRNA was reduced [13]. The same
effect was observed for the AGE-BSA-induced down-
regulation of Cx43 in this study [14].
Phosphorylation of the members of connexin, includ-
ing Cx43, is well known to play a key role in regulation
of gap-junction communication [20]. The effects of
phosphorylation on the communication can be either
enhancing or inhibiting. The phosphorylation status of
Cx43 is believed to affect the oligomerization of Cx43
into connexons and delivery of integral connexins to
justified locations [21-23]. Of the kinases involved in
phosphorylation of Cx43, ERK and p38 MAPK were
reported to attenuate the gap-junction communication
[24]. These data mainly came from non-endothelial
cells. On the other hand, activation of the ERK and p38
MAPK cascades was also reported to affect the expres-
sion level of Cx43 protein. In cultured smooth muscle
cells isolated from human saphenous vein, inhibition of
E R Ka n dp 3 8M A P Kb yu s i n gs i R N As p e c i f i ct ot h e
kinases were shown to attenuate the enhanced expres-
sion of Cx43 induced by angiotensin II [24]. Considering
in the present study that i) a close association between
the AGE-BSA-induced reduction in the Cx43 mRNA
level and the reduction of Cx43 protein is appeared; ii)
the down-regulation of endothelial Cx43 transcript and
protein by AGE-BSA is blocked by inhibitors of kinase
(ERK and p38 MAPK) cascades; and iii) phosphoryla-
tions of ERK and p38 MAPK were activated dose-
dependently, one may question whether in endothelial
cells after exposure to AGE-BSA there is a link between
activation of the MAPK and enhanced proteolysis of
Cx43, as reported in lens epithelial cells that phosphory-
lation is a signal for Cx43 proteins to enter a protea-
some-dependent degradation [25]. Moreover, activation
of the ERK and p38 MAPK cascades in endothelial cells
exposed to AGE-BSA results in regulation of Cx43 pro-
tein in a direction opposite to that seen for smooth
muscle cells [24]. Recent findings indicated that AGE-
Figure 9 Activation of ERK and p38 MAPK but not JNK
signaling pathways by AGE-BSA. Representative western blots of
ERK, phosphorylated ERK, p38 MAPK, phosphorylated p38 MAPK,
JNK, and phosphorylated JNK in cells treated with AGE-BSA for 2 (A)
and 6 hours (B). Phosphorylation of ERK and p38 MAPK was
activated dose-dependently but no such effect was seen for JNK.
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Page 10 of 12HSA (human serum albumin) could promote endothelial
progenitor cells (EPCs) senescence and apoptosis via
ERK and p38 MAPK pathways, leading to the down-reg-
ulation of the number of EPCs [26,27]. This decreases
the protective capacity of EPCs on atherosclerosis in
diabetic patients and increases their risks for cardiovas-
cular diseases [28]. Similarly, glucose, AGE, and methyl-
glyoxal, the precursor of AGE, could enhance apoptosis
of human cardiac myocytes and collagen deposition, an
important event of diabetic cardiomyopathy, in rat car-
diac fibroblasts accompanied by temporal activation of
ERK1/2, p38 MAPK, and nuclear O-GlcAcylation
[13,29,30]. Taken together, our findings in the present
study suggested that reduced Cx43 transcription is the
major mechanism underlying the down-regulation of
Cx43 protein in HAEC treated with AGE-BSA. More
studies are required to determine whether an increased
turnover rate of Cx43 plays a significant role in this pro-
cess. Although the down-regulation of Cx43 expression
was abolished by inhibitors, these rescued Cx43 proteins
may already lose their membrane-association and conse-
quently be unable to assemble properly to exert their
activity. It is also possible that gap junctions were
induced to partially close during the blockage of those
signaling pathways. These two phenomenons were
already reported in cells under certain physical and che-
mical offenses [31,32].
Down-regulation of Cx43 gap junctions in endothelial
cells by AGE-BSA has implications in the pathogenesis
of diabetic vasculopathy, which, as mentioned before,
starts with endothelial dysfunction [1]. Our recent find-
ings indicated that in endothelial cells down-regulation
of Cx43 per se activates the cells to a pathological sta-
tus, in which pro-coagulatory molecules, such as plasmi-
nogen activation inhibitor 1 and von Willebrand factor,
were up-regulated and the viability, angiogenic capacity,
and proliferation of the cells were reduced [33]. These
changes of endothelial cells due to insufficient expres-
sion of Cx43 may further aggravate the harmful effects
of AGE-BSA on the vascular cells.
Conclusions
This study provided the evidence that AGE-BSA down-
regulated Cx43 expression in HAEC, mainly through
reduced Cx43 transcription, and this process involved
activation of ERK and p38 MAPK.
Additional material
Additional file 1: Figure S1 -Comparison of the effects of AGE-BSA
and BSA on expression of Cx43 proteins, as detected by Western
blotting. No effects on the expression levels of Cx43 protein by BSA
were detected. Note that a dose-dependent reduction is only seen in
cells treated with AGE-BSA (A) but not with dialyzed, long-term stored
BSA (B). Cells were treated for 24 hours.
Additional file 2: Figure S2 -Comparison of different lysis buffers in
extraction of Cx43 proteins from HAEC treated with a serious
concentrations of AGE-BSA, as detected by Western blotting.N o
differences on the expression levels of Cx43 protein were detected using
both extraction buffers. Note that no difference in decreasing trends or
patterns of Cx43 proteins extracted from cells using either NP40 (A) or
SDS (B) buffers.
Additional file 3: Figure S3 -Comparison of anti-Cx43 antibodies of
various sources in detecting Cx43 proteins from cells treated with a
serious concentrations of AGE-BSA, as examined by Western
blotting. No differences on the expression levels of Cx43 proteins were
detected using both anti-Cx43 antibodies. Note the same pattern of a
dose-dependent reduction was seen using antibodies of different
sources (antibody used in A, from Chemicon; in B from, BD Biosciences).
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